Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Sergio Márquez-Peláez"'
Autor:
Maarten Postma, David Fisman, Norberto Giglio, Sergio Márquez-Peláez, Van Hung Nguyen, Andrea Pugliese, Jesús Ruiz-Aragón, Analia Urueña, Joaquin Mould-Quevedo
Publikováno v:
Vaccines, Vol 11, Iss 6, p 1089 (2023)
Influenza vaccination can benefit most populations, including adults ≥ 65 years of age, who are at greater risk of influenza-related complications. In many countries, enhanced vaccines, such as adjuvanted, high-dose, and recombinant trivalent/quadr
Externí odkaz:
https://doaj.org/article/255a02bf63cc40ec8fa659b2c1171322
Publikováno v:
Vaccines, Vol 11, Iss 2, p 427 (2023)
Influenza infections impose a high burden of morbidity and mortality among older adults, at great cost to individuals and society. Enhanced influenza vaccines, which contain either an immune adjuvant or higher than normal doses of influenza virus ant
Externí odkaz:
https://doaj.org/article/dc34995c06f9464d82ac9ba9406c77fd
Autor:
Anna Fochesato, Sara Sottile, Andrea Pugliese, Sergio Márquez-Peláez, Hector Toro-Diaz, Ray Gani, Piedad Alvarez, Jesús Ruiz-Aragón
Publikováno v:
Vaccines, Vol 10, Iss 8, p 1360 (2022)
Standard-dose quadrivalent influenza vaccines (QIV) are designed to provide protection against all four influenza strains. Adjuvanted QIV (aQIV), indicated for individuals aged 65+ years, combines MF59® adjuvant (an oil-in-water emulsion of squalene
Externí odkaz:
https://doaj.org/article/6d83a14be09648cba151b66c9c9f0861
Publikováno v:
Vaccines, Vol 10, Iss 2, p 176 (2022)
Influenza is a contagious respiratory disease that causes severe illness and death, particularly in elderly populations. Two enhanced formulations of quadrivalent influenza vaccine (QIV) are available in Spain. Adjuvanted QIV (aQIV) is available for
Externí odkaz:
https://doaj.org/article/5c627bb2c85944d1a6ca9a503cc76850
Publikováno v:
Revista Universitas Medica, Vol 52, Iss 2, Pp 191-206 (2011)
Introducción y objetivos. Los métodos actuales de ablación conllevan sistemas de navegación manual y ablación cardiaca, y presentan ciertas limitaciones. El objetivo de este trabajo ha sido evaluar la eficacia y seguridad de los nuevos sistemas
Externí odkaz:
https://doaj.org/article/ef4b3544d3c94466adfa24f4a10e4865
Background This report responds to a need to update the available information about incompatible living-donor kidney transplantation (LDKT) previously published in 2014 which, based on 14 case series and 1 cohort study, concluded that this type of tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c64198a72320996be63c805fefa2a0f
https://doi.org/10.52766/kpnf6027
https://doi.org/10.52766/kpnf6027
Introduction The first Global Health Sector Strategy on viral hepatitis 2016-2021 provided the initial roadmap for the elimination of viral hepatitis as a public health problem by 2030. With the development of new therapeutic strategies that allow th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c87dfebbae78e7438e3fefff9cc47893
https://doi.org/10.52766/cnnc1740
https://doi.org/10.52766/cnnc1740
Autor:
Juan-Antonio Blasco Amaro, Sergio Márquez-Peláez, Teresa Molina-Lopez, Workgroup Redets, Isabel Viguera-Guerra
Publikováno v:
International Journal of Technology Assessment in Health Care. 35:36-37
IntroductionThe Spanish network of health technology assessment (HTA) agencies (REDETS) is a collaboration of eight agencies, units and services, commissioned by the national and regional governments. The network coordinates work within a common meth
Autor:
Aurelio Cayuela, Remedios Otero Candelera, Emilia Barrot Cortés, Sergio Márquez Peláez, Luis Jara Palomares, Marta Ferrer Galván, María José Alfaro, Teresa Elías Hernández, Candela Caballero Eraso
Publikováno v:
Medicina Clínica. 138:327-331
Resumen Fundamento y objetivo Realizamos un estudio sobre seguridad, costes comparados y analisis de impacto presupuestario del tratamiento ambulatorio de pacientes con cancer y trombosis venosa profunda (TVP) frente al tratamiento hospitalario. Mate
Autor:
María del Mar Castellano-Zurera, José Luis Castro-Campos, Teresa Molina-Lopez, Carmen Navarro-Palenzuela, Sergio Márquez-Peláez
Publikováno v:
International Journal of Technology Assessment in Health Care. 33:86-87
INTRODUCTION:The Spanish Network of Agencies for Health Technology Assessment (REDETS) is a group of eight agencies, units and services, depending on National and Regional Governments that coordinate their work within a common methodological framewor